Masahiro Tsuboi
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY) (NCT04040361) | Masahiro Tsuboi | 2019-11-30 |
Track Masahiro Tsuboi automatically
Every clearance here is in the API, with alerts when new ones post.